Department of Hematology
Yufeng Shang has not added Biography.
If you are Yufeng Shang and would like to personalize this page please email our Author Liaison for assistance.
Current Advances in Immunotherapy for Acute Leukemia: An Overview of Antibody, Chimeric Antigen Receptor, Immune Checkpoint, and Natural Killer.
Frontiers in oncology , 2019 | Pubmed ID: 31616632
TGF-β receptor inhibitor LY2109761 enhances the radiosensitivity of gastric cancer by inactivating the TGF-β/SMAD4 signaling pathway.
Aging 10, 2019 | Pubmed ID: 31631064
Scoring systems for predicting mortality for severe patients with COVID-19.
EClinicalMedicine Jul, 2020 | Pubmed ID: 32766541
Novel biomarkers for the prediction of COVID-19 progression a retrospective, multi-center cohort study.
Virulence 12, 2020 | Pubmed ID: 33172355
Factors affecting antibody response to SARS-CoV-2 in patients with severe COVID-19.
Journal of medical virology 02, 2021 | Pubmed ID: 33289107
Impact of Treatment Regimens on Antibody Response to the SARS-CoV-2 Coronavirus.
Frontiers in immunology , 2021 | Pubmed ID: 33936026
Biological Characteristics of Umbilical Cord Mesenchymal Stem Cells and Its Therapeutic Potential for Hematological Disorders.
Frontiers in cell and developmental biology , 2021 | Pubmed ID: 34012958
Public screening for COVID-19 in Wuhan, China and beware of the antibody positive in women and tumor patients.
Journal of medical virology 04, 2022 | Pubmed ID: 34850404
Evaluation of prognostic staging systems of multiple myeloma in the era of novel agents.
Hematological oncology Apr, 2022 | Pubmed ID: 34860428
Therapeutic Plateletpheresis in Patients With Thrombocytosis: Gender, Hemoglobin Before Apheresis Significantly Affect Collection Efficiency.
Frontiers in medicine , 2021 | Pubmed ID: 35004735
Development of a Risk Assessment Model for Early Grade ≥ 3 Infection During the First 3 Months in Patients Newly Diagnosed With Multiple Myeloma Based on a Multicenter, Real-World Analysis in China.
Frontiers in oncology , 2022 | Pubmed ID: 35372017
关于 JoVE
版权所属 © 2024 MyJoVE 公司版权所有,本公司不涉及任何医疗业务和医疗服务。